2,472 Shares in Cabot Co. (NYSE:CBT) Bought by XTX Topco Ltd

XTX Topco Ltd bought a new position in shares of Cabot Co. (NYSE:CBT) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,472 shares of the specialty chemicals company’s stock, valued at approximately $227,000.

A number of other institutional investors have also added to or reduced their stakes in the business. UBS Group AG increased its holdings in shares of Cabot by 51.1% in the 4th quarter. UBS Group AG now owns 83,355 shares of the specialty chemicals company’s stock worth $6,960,000 after buying an additional 28,204 shares during the last quarter. TFO Wealth Partners LLC lifted its position in Cabot by 63,400.0% in the 4th quarter. TFO Wealth Partners LLC now owns 1,905 shares of the specialty chemicals company’s stock worth $159,000 after buying an additional 1,902 shares during the last quarter. Evoke Wealth LLC purchased a new stake in Cabot in the fourth quarter worth approximately $772,000. Campbell & CO Investment Adviser LLC bought a new position in Cabot during the fourth quarter valued at approximately $1,062,000. Finally, Quadrature Capital Ltd raised its stake in shares of Cabot by 267.3% during the fourth quarter. Quadrature Capital Ltd now owns 11,380 shares of the specialty chemicals company’s stock worth $950,000 after acquiring an additional 8,282 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CBT has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. StockNews.com lowered Cabot from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 24th. Finally, UBS Group dropped their price objective on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus target price of $101.75.

Cabot Trading Down 0.7 %

NYSE CBT opened at $110.83 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot Co. has a fifty-two week low of $65.10 and a fifty-two week high of $113.12. The stock has a market cap of $6.12 billion, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.01 and a beta of 1.19. The stock has a 50 day simple moving average of $101.37 and a two-hundred day simple moving average of $97.48.

Cabot (NYSE:CBT) last posted its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period last year, the company posted $1.42 EPS. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, analysts forecast that Cabot Co. will post 7.07 earnings per share for the current year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 30th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, August 30th. Cabot’s payout ratio is presently 21.77%.

Insider Buying and Selling at Cabot

In related news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at $5,968,839.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the transaction, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,939 shares of company stock valued at $7,308,812. 3.07% of the stock is currently owned by company insiders.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.